Tom has a broad range of experience advising on public and private M&A, private equity and joint ventures.
Tom acts for a variety of clients across different sectors and jurisdictions.
Advising Jazz Pharmaceuticals plc, a biopharmaceutical company based in Ireland, on its acquisition of GW Pharmaceuticals plc for a total consideration of $7.2bn, announced in February 2021.
Advising Smith & Williamson on the restructuring of Tilney merger and Warburg Pincus investment.
Advising Spectris in relation to its acquisition of Concept Life Sciences from Equistone Partners.
Advising L-3 Technologies on its acquisition of C.K. Industrial Engineers Limited.
Advising Keyhaven Capital Partners in relation to the sale of Augur Financial Opportunities II to SALU Capital.
